Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta

por Siebert, Nikolai, Zumpe, Maxi, Schwencke, Christian Heinrich, Biskupski, Simon, Troschke-Meurer, Sascha, Leopold, Justus, Zikoridse, Alexander, Lode, Holger N.
Publicado 2023